Publication | Closed Access

Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

VaccinologyVaccinationVaccine DevelopmentCardiovascular DiseaseCerebrovascular DiseaseVaccine EfficacyInfluenza VaccineFlu VaccinationPublic HealthMedicineInfluenza Vaccines